178 related articles for article (PubMed ID: 32343689)
21. BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance.
Ferretti R; Bhutkar A; McNamara MC; Lees JA
Genes Dev; 2016 Jan; 30(1):18-33. PubMed ID: 26679841
[TBL] [Abstract][Full Text] [Related]
22. Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma.
Proctor E; Waghray M; Lee CJ; Heidt DG; Yalamanchili M; Li C; Bednar F; Simeone DM
PLoS One; 2013; 8(2):e55820. PubMed ID: 23437065
[TBL] [Abstract][Full Text] [Related]
23. PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines.
Li J; Vangundy Z; Poi M
Anticancer Res; 2020 Jan; 40(1):133-141. PubMed ID: 31892561
[TBL] [Abstract][Full Text] [Related]
24. PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.
Dimri M; Cho JH; Kang M; Dimri GP
J Biol Chem; 2015 Jan; 290(5):3033-44. PubMed ID: 25505268
[TBL] [Abstract][Full Text] [Related]
25. LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c-MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer.
Xie J; Ni J; Shi H; Wang K; Ma X; Li W; Peng B
Cancer Med; 2023 Mar; 12(5):5718-5735. PubMed ID: 36208024
[TBL] [Abstract][Full Text] [Related]
26. BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance.
Shahi MH; York D; Gandour-Edwards R; Withers SS; Holt R; Rebhun RB
PLoS One; 2015; 10(6):e0131006. PubMed ID: 26110620
[TBL] [Abstract][Full Text] [Related]
27. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
[TBL] [Abstract][Full Text] [Related]
28. Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG.
Balakrishnan I; Danis E; Pierce A; Madhavan K; Wang D; Dahl N; Sanford B; Birks DK; Davidson N; Metselaar DS; Meel MH; Lemma R; Donson A; Vijmasi T; Katagi H; Sola I; Fosmire S; Alimova I; Steiner J; Gilani A; Hulleman E; Serkova NJ; Hashizume R; Hawkins C; Carcaboso AM; Gupta N; Monje M; Jabado N; Jones K; Foreman N; Green A; Vibhakar R; Venkataraman S
Cell Rep; 2020 Oct; 33(3):108286. PubMed ID: 33086074
[TBL] [Abstract][Full Text] [Related]
29. BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1.
Zhu S; Zhao D; Yan L; Jiang W; Kim JS; Gu B; Liu Q; Wang R; Xia B; Zhao JC; Song G; Mi W; Wang RF; Shi X; Lam HM; Dong X; Yu J; Chen K; Cao Q
Nat Commun; 2018 Feb; 9(1):500. PubMed ID: 29402932
[TBL] [Abstract][Full Text] [Related]
30. Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
Yin T; Zhang Z; Cao B; Duan Q; Shi P; Zhao H; Camara SN; Shen Q; Wang C
Oncotarget; 2016 Jun; 7(24):37192-37204. PubMed ID: 27177084
[TBL] [Abstract][Full Text] [Related]
31. Bmi1 gene silencing inhibits the proliferation and invasiveness of human hepatocellular carcinoma cells and increases their sensitivity to 5-fluorouracil.
Zhang R; Xu LB; Yue XJ; Yu XH; Wang J; Liu C
Oncol Rep; 2013 Mar; 29(3):967-74. PubMed ID: 23242307
[TBL] [Abstract][Full Text] [Related]
32. Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.
Xu CR; Lee S; Ho C; Bommi P; Huang SA; Cheung ST; Dimri GP; Chen X
Mol Cancer Res; 2009 Dec; 7(12):1937-45. PubMed ID: 19934271
[TBL] [Abstract][Full Text] [Related]
33. Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells.
Liang W; Zhu D; Cui X; Su J; Liu H; Han J; Zhao F; Xie W
Mol Cell Biochem; 2013 Oct; 382(1-2):283-91. PubMed ID: 23820733
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer.
Buechel M; Dey A; Dwivedi SKD; Crim A; Ding K; Zhang R; Mukherjee P; Moore KN; Cao L; Branstrom A; Weetall M; Baird J; Bhattacharya R
Mol Cancer Ther; 2018 Oct; 17(10):2136-2143. PubMed ID: 30026381
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
Wu D; He X; Wang W; Hu X; Wang K; Wang M
Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
[TBL] [Abstract][Full Text] [Related]
36.
Ganaie AA; Beigh FH; Astone M; Ferrari MG; Maqbool R; Umbreen S; Parray AS; Siddique HR; Hussain T; Murugan P; Morrissey C; Koochekpour S; Deng Y; Konety BR; Hoeppner LH; Saleem M
Clin Cancer Res; 2018 Dec; 24(24):6421-6432. PubMed ID: 30087142
[TBL] [Abstract][Full Text] [Related]
37. BMI1 is downregulated by the natural compound curcumin, but not by bisdemethoxycurcumin and dimethoxycurcumin.
Adeyeni TA; Khatwani N; San K; Ezekiel UR
Physiol Rep; 2016 Aug; 4(16):. PubMed ID: 27550987
[TBL] [Abstract][Full Text] [Related]
38. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
Shahi MH; Farheen S; Mariyath MP; Castresana JS
Tumour Biol; 2016 Nov; 37(11):15107-15114. PubMed ID: 27662839
[TBL] [Abstract][Full Text] [Related]
39. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
M JR; S V
Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
[TBL] [Abstract][Full Text] [Related]
40. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
Dimri M; Kang M; Dimri GP
Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
